-
Jen Moughalian
… from the University of Maryland and holds a Bachelor of Arts from the University of Richmond. She also holds a …
-
Use of LRRK2 and Lysosomal Biomarker Signatures to Differentiate Idiopathic and Monogenetic Parkinson’s Disease
… clinical trial or treatment. Here, we will use state of the art technologies to analyze peripheral blood and urine … of PD and those whose PD is idiopathic (cause unknown). In particular, we will assess the activation status of LRRK2, a … We will deploy established and novel state-of-the-art techniques for analyzing LRRK2 pathway activity and …
-
Lisa Boudreau
… a 10-year commitment to Harvard University’s Faculty of Arts and Sciences as associate director of the Harvard …
-
The New York Times: Andy Grove's Prescription for Health Care
November 18, 2009
… after he found out he had cancer, into the state of the art of treatments. The piece, most of all, displayed his … Grove, characteristically, offers a crisp one. “It’s the art of taking laboratory, one-off discoveries and putting … and Alzheimer’s disease. “That kind of cure will start as a $200,000 procedure, but it should quickly become a …
-
Breakthrough Prize Offers $3 Million for Parkinson’s Research Excellence
September 10, 2013
… Prize, you have the power to put them in the running,” said Art Levinson, Chairman of Apple Inc., Genentech, and The …
-
Alfred Goldberg, PhD
… companies, is a Fellow of the American Academy of Arts & Sciences and is among the top 1% most cited authors …